Conference abstracts, posters & presentations

Displaying 1 - 25 of 16008
Drupal spam blocked by CleanTalk.
ECCMID 29th
Title Author Yearsort ascending No. Poster
Antimicrobial activity of an antiseptic miramistin Ali Osmanov1, David W. Denning*1 2019 O0735
Optimisation of Aspergillus DNA extraction from simulated samples and clinical serum and bronchoalveolar lavage samples, as a precursor to commercial PCR assay consideration for routine service, in an NHS clinical diagnostic microbiology laboratory Emma Brown1, Fiona Price*1, Christopher Holmes1, Daxa Patel1, Nelun Perera1 2019 P2190
Current epidemiology of infections in febrile neutropenia episodes from a large cohort of haematological patients Pedro Puerta1, Celia Cardozo*1, Maria Suárez-Lledó2, Olga Rodríguez Nuñez1, Laura Morata1, Csaba Feher1, Francesc Marco Reverte3, Mariana Chumbita1, Tycho Stephan Baumann2, Carmen Martínez2, Eva Giné2, José Antonio Martínez Martínez1, José Mensa1, Montserrat Rovira2, Jordi Esteve2, Alex Soriano1, Carolina Garcia Vidal1 2019 P0650
Discovery and characterisation of a novel mechanism of clinical triazole antifungal-resistance: mutations in the Aspergillus fumigatus HMG-CoA reductase gene, hmg1 Jeffrey M. Rybak*1, Nathan Wiederhold2, Josie E. Parker3, Steven L. Kelly3, P. David Rogers1, Jarrod R. Fortwendel1 2019 O1128
The use of aerosolized amphotericin B for fungal infection prophylaxis post-lung transplantation Dema Alissa*1, Reem Almaghrabi1, Imran Nizami1, Ghazwa Korayem2, Amal Saleh2, Amjad Alshamrani2, Norah Alrajeh2, Nour Albegami2, Reema Al Muraybidh2, Saba Bin Huwaimel2 2019 P2280
Standardisation and application of simple and low cost tetra primer ARMS-PCR for detection of TR34/L98H mutation in triazole resistant Aspergillus fumigatus Sadegh Khodavaisy*1, Shahram Mahmoudi2, Hamid Badali3, Aleksandra Barac4, Mohammad Kord2 2019 O0833
Identification of a possible mechanism of Aspergillus flavus CYP51A-mediated resistance in serial isolates obtained from chronic aspergillosis patients Samuel Hill*1, Rikesh Masania1, Caroline Moore1, Darin Hassan1, Chris Kosmidis2, Lily Novak-Frazer1 2019 P2169
Pulmonary aspergillosis among patients with chronic obstructive pulmonary disease admitted to intensive care unit: preliminary results of an observational study Claudio Penido *1, Mayra Menegueti1, Evelin Cechinatti2, Caio Cirino2, Andre Amate Neto2, Fernando Bellissimo-Rodrigues3 2019 P0153
Evaluation of the LD Bio Aspergillus ICT lateral flow assay as a point-of-care test for serological antibody detection in chronic pulmonary aspergillosis Elizabeth Hunter*1, Malcolm Richardson1,2, David W. Denning1,2 2019 O1122
Voriconazole intra-patient variability associated with worse clinical outcomes in cystic fibrosis lung transplant recipients Paolo Pavone*1,2, Setareh Davoudi2, Sabina Herrera2, Cecilia Chaparro2, Lianne Singer2, Atul Humar2, Deepali Kumar2, Coleman Rotstein2, Shahid Husain2 2019 O0736
Molecular detection of Aspergillus and corresponding azole resistance markers: systematic comparison of two commercial PCR test kits, AsperGenius and MycoGENIE Daniel Goldenberger*1, Nina Khanna2, Elisabeth Wehrle3,2, Helena Seth-Smith4,1, Doris Hohler1, Vladimira Hinic1, Adrian Egli4,1 2019 P2192
Invasive fungal infections among HIV patients in the time of HAART: a 16-year retrospective study in a tertiary care centre in Spain Silvio Ragozzino*1, Alicia García Señán1, Hugo Guillermo Ternavasio De La Vega1, Miguel Marcos1, Miguel Cordero Sánchez1 2019 P0696
Parasexual recombination as an adaptation strategy in Aspergillus persistence Tobias Engel*1, Paul E. Verweij1, Fons Debets2, Eveline Snelders2 2019 O1129
Rapid genotypic methods to speed up the diagnosis of polymicrobial bloodstream infections Brigitte Lamy*1, Caroline Bonnefoy1, Mathilde Vannini1, Nicolas Degand1, Alice Gaudart1, Romain Lotte1, Caroline Touati1, Raymond Ruimy1 2019 P2361
Improved serological diagnosis of chronic pulmonary aspergillosis in ImmunoCAP IgG-negative patients using the LD Bio Aspergillus ICT lateral flow assay Elizabeth Hunter*1, Bayu Wilopo1, Malcolm Richardson1,2, David W. Denning1,2 2019 O0836
First detection of TR34/L98H Aspergillus fumigatus mutants in Switzerland Silvio Ragozzino*1, Daniel Goldenberger2, Stefan Zimmerli3, Konrad Mühlethaler4, Dionysios Neofytos5, Arnaud Riat6, Katia Boggian7, Nolte Oliver 8, Anna Conen9, Hans Fankhauser10, Frederic Lamoth11, Nina Khanna1 2019 P2170
Invasive pulmonary aspergillosis after heart transplantation: a 7-year single-centre experience Karina Monosova*1, Maria Simonenko1, Ksenia Zagorodnikova1, Petr Fedotov1, Yulia Sazonova1, Rubinchik Vadim1, Mikhail Karpenko1 2019 P0156
Mould surveillance at a tertiary university hospital documents increasing azole resistance in Aspergillus among Danish cystic fibrosis patients Malene Risum*1, Helle Krogh Johansen2,3, Raluca Datcu1, Rasmus Krøger Hare1, Karin Meinike Jørgensen1, Maiken C. Arendrup1,2,3 2019 O1124
Isavuconazole kinetic exploration for clinical practice Lea Darnaud1, Fabien Lamoureux2, Cendrine Godet3, Sabdrine Pontier4, Alexa Debard5, Nicolas Venisse3, Pauline Martins3, Didier Concordet6, Peggy Gandia*6,1 2019 O0737
Evaluation of DermaGenius, a multiplex real-time PCR to identify dermatophytes directly from specimens Christina Kuenzli1, Cornelia Ottiger2, Hans Fankhauser2, Michael Oberle*2 2019 P2199
Pulmonary colonisation with moulds and Exophiala dermatitidis in adult cystic fibrosis patients Nelly Daniela Zurita Cruz*1, Arturo Manuel Fraile Torres1, Ayla Yarci Carrión1, Leticia Fontán García-Rodrigo1, Belén Fernández-Caso1, Josefa Barba Almeida1, Rosa M. Girón1, Buenaventura Buendia1 2019 P1109
Use of ibrexafungerp (formerly SCY-078) to treat severe azole-refractory oesophageal candidiasis: a case report from the FURI study Jose Vazquez*1, Aprile Osborn 2019 P0125
Protecting the patients from environmental fungal contamination during maintenance works of an haematology ward with laminar airflow system: effectiveness of a set of measures Florence Le Gallou*1, Wiesel Sophie1, Anne-Claire Guille Des Buttes1, Thomas Gaumart1, Véronique Sellin1, Emilie Racine2, Christine Cartier2, Didier Lepelletier1 2019 P2634
In vivo pharmacodynamic evaluation of the novel antifungal agent APX001 in a murine model of invasive pulmonary aspergillosis against wild-type and Cyp51 mutant Aspergillus fumigatus strains Alex Lepak*1, Miao Zhao2, David Andes1 2019 O1066
In vitro antifungal susceptibility testing of cryptic species of Aspergillus: a multi-centre study Sebastien Imbert*1,2, Anne Cecile Normand1, Frédéric Gabriel3, Christine Bonnal4, Laurence Lachaud5, Damien Costa6, Sophie Cassaing7, Lilia Hasseine8, Christine Schuttler9, Lise Kristensen 10, Hélène Raberin11, Sophie Brun 12, Renaud Piarroux1, Arnaud Fekkar1,2 2019 P2171

Pages